Aging Clinical and Experimental Research (ACER) is committed to advancing understanding and improving outcomes in gerontology. In line with the journal's scope, the topic "Osteosarcopenia" emerges as a pivotal area of inquiry. Manuscripts exploring the following themes are particularly encouraged:
Pathophysiology and Mechanisms: Investigations into the underlying mechanisms linking osteoporosis and sarcopenia, including shared pathways, molecular interactions, and the bidirectional relationship between bone and muscle health.
Clinical Implications and Complications: Examination of the clinical implications of osteoporosis-sarcopenia overlap, such as increased fracture risk, functional impairment, falls, and mortality in aging populations.
Diagnostic Strategies and Assessment Tools: Development and validation of innovative diagnostic methods and assessment tools to detect and quantify osteoporosis and sarcopenia, individually and in combination, facilitating early detection and targeted interventions.
Interventions and Management Approaches: Exploration of novel interventions and management strategies, including exercise regimens, pharmacological treatments, nutritional interventions, and multidisciplinary approaches to mitigate the adverse effects of osteoporosis-sarcopenia complex.
ACER invites original research articles, reviews, and clinical studies that contribute to advancing knowledge and informing practice in the field of osteoporosis and sarcopenia. By addressing this critical intersection, ACER aims to foster interdisciplinary collaboration and promote holistic approaches to optimize bone and muscle health in aging populations.